Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 20/20 | 0.80 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9976505 | 0.91 | F10 (0.79) | F10 | |
| SCHEMBL5404866 | 0.89 | F10 (1.00) | F10 | |
| Hydrochloric Acid SCHEMBL5428074 | 0.88 | F10 (1.00) | F10 | |
| SCHEMBL9976507 | 0.85 | F10 (0.78) | F10 | |
| SCHEMBL9976490 | 0.83 | F10 (0.87) | F10 | |
| SCHEMBL5396391 | 0.82 | F10 (0.86) | F10 | |
| SCHEMBL9976496 | 0.82 | F10 (0.72) | F10 | |
| SCHEMBL14593818 | 0.81 | F10 (0.81) | F10 | |
| SCHEMBL9979805 | 0.81 | F10 (0.83) | F10 | |
| SCHEMBL9976489 | 0.79 | F10 (1.00) | F10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE43481-E1 | Diazepan derivatives or salts thereof | ASTELLAS PHARMA INC. (JP) | 2012-06-19 | — | — | US | disclosed |
| US-RE43481-E1 | Diazepan derivatives or salts thereof | ASTELLAS PHARMA INC. (JP) | 2012-06-19 | — | — | US | disclosed |
| US-7307074-B2 | Activated blood coagulation factor X inhibitor and also to such a pharmaceutical agent and particularly has an excellent activity by oral administration | ASTELLAS PHARMA INC. (JP) | 2007-12-11 | — | — | US | disclosed |
| US-7307074-B2 | Activated blood coagulation factor X inhibitor and also to such a pharmaceutical agent and particularly has an excellent activity by oral administration | ASTELLAS PHARMA INC. (JP) | 2007-12-11 | — | — | US | disclosed |